Literature DB >> 29051092

Targeted surveillance of nosocomial infection in intensive care units of 176 hospitals in Jiangsu province, China.

Y Li1, X Cao2, H Ge1, Y Jiang3, H Zhou4, W Zheng4.   

Abstract

BACKGROUND: Nosocomial infections (NIs) impact care and costs in hospitals across the globe. There are few data on targeted surveillance of NI in intensive care units (ICUs), and data specific to the risk factors for NI are especially limited.
METHODS: One hundred and seventy-six secondary and tertiary hospitals performed NI targeted surveillance in their ICUs. The data were collected and summarized by Minke software, then fed back once per quarter.
FINDINGS: The incidence of NI appeared to decrease, and the incidence of NI per 1000 patient-days and adjusted incidence were 25.63‰ and 7.41‰ in 2010, and 9.73‰ and 2.76‰ in 2015, respectively. The NI incidence in general hospitals was higher than in specialized hospitals. The incidence of central-line-associated bloodstream infection (CLABSI) and catheter-associated urinary tract infection (CAUTI) appeared to decrease, and the incidence of ventilator-associated pneumonia (VAP) decreased markedly from 20.33‰ to 2.76‰. There was no statistically significant difference among ICUs. The six most frequently found pathogen-caused NIs were Acinetobacter baumannii (AB), Klebsiella pneumoniae (KP), Pseudomonas aeruginosa (PA), Staphylococcus aureus, Candida albicans, and Escherichia coli (E. coli). The isolation rate of carbapenem-resistant Gram-negative bacilli were carbapenem-resistant AB 80.53%, carbapenem-resistant PA 39.94%, carbapenem-resistant KP (CRKP) 24.86%, and carbapenem-resistant E. coli 9.23%. The isolation rate of meticillin-resistant S. aureus (MRSA) was 66.30%. The increasing trend of CRKP was statistically significant as analysed by the regression model.
CONCLUSION: The incidences of VAP, CAUTI, and CLABSI were high in ICUs, and multidrug-resistant organisms were the primary pathogens of NI. The implementation of targeted surveillance may determine the risk factors of NI so that effective intervention measures can be taken to reduce the incidence of NI in ICU patients.
Copyright © 2017 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Intensive care unit; Nosocomial infection; Resistance; Targeted surveillance

Mesh:

Year:  2017        PMID: 29051092     DOI: 10.1016/j.jhin.2017.10.009

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  8 in total

1.  Resistance traits and molecular characterization of multidrug-resistant Acinetobacter baumannii isolates from an intensive care unit of a tertiary hospital in Guangdong, southern China.

Authors:  Zhuo-Ran Chen; Hui-Wu Guo; Jun Liu; Qing Pan; Mao-Zhang Fu; Ying-Kun Qiu; Nai-Kei Wong; Yuan-Chun Huang
Journal:  Int Microbiol       Date:  2022-01-31       Impact factor: 3.097

Review 2.  What intensive care registries can teach us about outcomes.

Authors:  Abi Beane; Jorge I F Salluh; Rashan Haniffa
Journal:  Curr Opin Crit Care       Date:  2021-10-01       Impact factor: 3.359

3.  A comparison of diagnostic algorithms and clinical parameters to diagnose ventilator-associated pneumonia: a prospective observational study.

Authors:  Farshid Rahimibashar; Andrew C Miller; Mojtaba H Yaghoobi; Amir Vahedian-Azimi
Journal:  BMC Pulm Med       Date:  2021-05-13       Impact factor: 3.317

4.  Determinants of Mortality in Patients with Nosocomial Acinetobacter baumannii Bacteremia in Southwest China: A Five-Year Case-Control Study.

Authors:  Shuangshuang Yang; Jide Sun; Xianan Wu; Liping Zhang
Journal:  Can J Infect Dis Med Microbiol       Date:  2018-06-03       Impact factor: 2.471

5.  A 7-year surveillance of the drug resistance in Klebsiella pneumoniae from a primary health care center.

Authors:  Guogang Li; Sheng Zhao; Sipei Wang; Yingqian Sun; Yangxiao Zhou; Xinling Pan
Journal:  Ann Clin Microbiol Antimicrob       Date:  2019-11-09       Impact factor: 3.944

Review 6.  Surveillance strategies using routine microbiology for antimicrobial resistance in low- and middle-income countries.

Authors:  Cherry Lim; Elizabeth A Ashley; Raph L Hamers; Paul Turner; Thomas Kesteman; Samuel Akech; Alejandra Corso; Mayfong Mayxay; Iruka N Okeke; Direk Limmathurotsakul; H Rogier van Doorn
Journal:  Clin Microbiol Infect       Date:  2021-06-07       Impact factor: 13.310

7.  Chlorhexidine locking device for central line infection prevention in ICU patients: protocol for an open-label pilot and feasibility randomized controlled trial.

Authors:  Nasim Zamir; Makena Pook; Ellen McDonald; Alison E Fox-Robichaud
Journal:  Pilot Feasibility Stud       Date:  2020-02-18

8.  A scoping review of registry captured indicators for evaluating quality of critical care in ICU.

Authors:  Issrah Jawad; Sumayyah Rashan; Chathurani Sigera; Jorge Salluh; Arjen M Dondorp; Rashan Haniffa; Abi Beane
Journal:  J Intensive Care       Date:  2021-08-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.